Dr. Jackilen Shannon is a nutritional epidemiologist with a strong track record of investigation in the role of diet and nutrition in carcinogenesis. She joined Oregon Health and Science University in 2000. She completed a doctoral degree program in Nutrition with a minor in Epidemiology at The University of North Carolina, Chapel Hill, and an NIH-NCI post-doctoral training fellowship in cancer epidemiology at the Fred Hutchinson Cancer Research Center.

Research Interests

The primary focus of Dr. Shannon’s work has been to unveil the nutritional factors that promote the development and progression of human prostate cancer. In 2003, Dr. Shannon received funding for an NCI Career Transition Development Award. This non-mentored award is designed to support the development of new investigators in cancer prevention. Dr. Shannon’s stated research focus is on fatty acids and prostate cancer prevention, with a primary focus on the use of molecular epidemiologic methods. This particular award has supported her on-going case-control study of dietary and red cell w-3 fatty acids and inflammatory mediators in prostate cancer risk. Dr. Shannon has also received funding through a Department of Defense Idea grant to support a placebo-controlled trial of the effect of fish oil supplementation on prostate tissue FAS expression in biopsy negative men undergoing repeat prostate biopsy.

(Use the link below for a complete list of publications)

Coriaty Nelson Z, Ray RM, Wu C, Stalsberg H, Porter P, Lampe JW, Patterson R, Shannon J, Horner N, Li W, Fitzgibbons D, Wang WW, Hu YW, Gao DL, Thomas DB. A Case-Control Study of Risk Factors for Fibroadenoma in Shanghai. Am J Epid 2006; submitted.

Shannon J, Shikany JM, Barrett-Connor E, Marshall LM, Bunker CH, Chan JM, Katie L. Stone, Orwoll E, for the Osteoporotic Fractures in Men (MrOS) Research Group. Demographic Factors Associated with the Diet Quality of Older US Men: Baseline Data from the Osteoporotic Fractures in Men (MrOS) Study. PH Nutrition 2006; submitted.

Shannon J, Tewoderos S, Garzotto M, Beer T, Derenick R, Palma A Farris PE. HMG CoA Reductase Inhibitor Use and Prostate Cancer Risk: A Case-Control Study. Am J Epidemiol 2005; 162:318-25. Abstract

Shannon J, Ray RM, Wu C, Nelson ZC, Gao DL, Li GD, Wei HY, Lampe JW, Horner N, Abouta JS, Patterson R, Fitzgibbons ED, Thomas DB. Food and botanical groupings and risk of breast cancer: Cancer Epidemiol Biomarker & Prev 2005; 14:81-90. Abstract

Li W, Ray RM, Lampe JW, Lin M-G, Gao DL, Wu C, Nelson ZC, Fitzgibbons ED, Horner N, Hu YW, Shannon J, Abouta JS, Patterson R, Stalsberg H, Thomas DB. Risk factors for progression of proliferative fibrocystic breast conditions to invasive breast cancer: a nested case-control study in Shanghai, China. Int J Cancer. 2005; 115: 981-93. Abstract

more publications